Top 21 MDClone investors
The most complete profiles first. Showing 21 of 21.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Alon AltschulerVerified
Venture Capital, Angel Group, Private Equity Firm · United States
Health CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more
Contact details available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Roy WiesnerVerified
Venture Capital, Angel Group, Private Equity Firm · Israel
Health CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
David Gussarsky
Venture Capital, Investor · Israel
Series BMessagingEnterprise SoftwareEnterprise InfrastructureClean TechnologyPortfolio: Tripledot Studios, MDClone, Elastifile, Datorama and 6 more
Contact details available
Gur Roshwalb
Venture Capital, Angel Group, Investor · Israel
SeedHealth CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 24 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Todd Sone
Venture Capital, Angel Group, Private Equity Firm · Israel
SeedHealth CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 22 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Dorit Sokolov
Angel Group · Israel
Health CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more
Contact details available
Eran Lerer
Angel Group · Israel
Health CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Omri Strul
Angel Group · Israel
Health CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more
Contact details available
Victoria Balannik
Angel Group · Israel
Health CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more
Contact details available
Yaron Daniely
Angel Group · Israel
Health CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more
Contact details available
Yifat Segev
Angel Group · Israel
Health CareHospitalsGeneticsAlternative MedicinePortfolio: CuResponse, Karius, AbSci, CartiHeal and 21 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Galecto10
- Harmony Biosciences10
- Cytek Biosciences10
- Apos Therapy10
- Miaoshou Doctor10
- Nuvation Bio10
- Vocalis Health10
- Azura Ophthalmics10
- ORIC Pharmaceuticals10
- Abbisko Therapeutics10
- Immvira10
Frequently asked questions
How many MDClone investors are on Angel Roster?
Angel Roster lists 21 MDClone investors. 6 of them (29%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (13), Venture Capital Firms (10) and Angel Groups (10). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do MDClone investors invest in?
Among those that list a stage, the most common are Seed (7), Series A (5) and Series B (1).
Where are MDClone investors based?
Most are based in Israel (12), the United States (8) and China (1).
Which companies have MDClone investors backed?
The most-backed portfolio companies among them are Galecto (10), Harmony Biosciences (10), Cytek Biosciences (10), Apos Therapy (10) and Miaoshou Doctor (10).
How do I contact MDClone investors?
Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.